Dr. Jeff Himawan has served on the board of directors since July 2007. Dr. Himawan has been a managing director of Essex Woodlands Health Ventures, a venture capital firm, since 2004. Prior to that, he was an adjunct partner at Essex Woodlands from 1999 to 2001, and he was a venture partner from 2001 to 2004. Dr. Himawan co-founded Seed-One Ventures, an early-stage venture capital firm, where he served as a managing director from 1996 to 2001. Dr. Himawan also currently serves on the board of directors of MediciNova Inc., a public biopharma company, and NexEos Bio Inc., a private biotechnology company. Previously, Dr. Himawan served on the board of directors of Catalyst Biosciences Inc., a public biopharma company, from 2010 to 2020.

Dr. Himawan received a Bachelor of Science in biology from the Massachusetts Institute of Technology and a doctorate in biological chemistry and molecular pharmacology from Harvard University.